A committee for the European Medicine Agency has recently reaffirmed a decision to keep the popular diabetes medication, Actos, on the shelves despite the fact that it has been linked to an increased risk of bladder cancer.
Earlier in the year, it was advised by the Committee of Medicinal Products for Human Use, that a new warning label should be put onto Actos bottles in order to explain the risk of bladder cancer. Even though it was said to put a warning on the bottle, it was never urged that the drug be taken off the shelves.
In June, France and Germany issued warning to doctors that they should not prescribe the drug anymore. The CMPH has made a statement that says that Actos can be prescribed to certain patients who have taken other forms of treatment and they have failed to work. The EMA has decided to keep the product on the market at this time for those reasons.
If you or a loved one has taken Actos and developed bladder cancer without being warned of the possible risks,you need experienced representation on your side. Contact the Actos lawsuit lawyers of Williams Kherkher today by calling 800-641-9810 today.